Journal Article

Allopurinol-Induced Orotidinuria

Valle, David, Hauser, Elizabeth R, Brusilow, Saul W, Finkelstein, Janice E

1990

Overview

Ornithine carbamoyltransferase is an X-linked mitochondrial enzyme expressed in hepatocytes and enterocytes. A deficiency of this enzyme results in central nervous system dysfunction, which may be fatal in newborn boys. Milder forms are seen in older boys and girls and in adults. Establishing the carrier status of women at risk for ornithine carbamoyltransferase deficiency is important for determining reproductive and medical risks for affected women. We report a test to establish the carrier status of women at risk for ornithine carbamoyltransferase deficiency. This test relies on the allopurinol-induced accumulation of orotidine, whose synthesis is stimulated by carbamoyl phosphate, a substrate that accumulates in ornithine carbamoyltransferase deficiency. We used anion-exchange, high-performance liquid chromatography to measure urinary orotidine and orotic acid excretion after the administration of a 300-mg oral dose of allopurinol in 24 women who were obligate heterozygotes, 13 who were probable heterozygotes, 15 mothers of affected boys from monoplex families (families with only one affected member), 12 mothers of affected girls from monoplex families, and 25 normal, unrelated women who were not carriers. Urinary orotidine excretion was increased 3 SD or more above the mean value for the normal women in 95.8 percent of the obligate heterozygotes, 84.6 percent of the probable heterozygotes, 73.3 percent of the mothers of affected boys in monoplex families, and 33.3 percent of the mothers of affected girls in monoplex families, thus establishing that these women were carriers of a mutant ornithine carbamoyltransferase allele. The presence of allopurinol-induced orotic aciduria was not as sensitive or specific an indicator of carrier status as the presence of orotidinuria. We conclude that measurement of urinary orotidine excretion after the administration of allopurinol is a simple and reliable test for the identification of women who are heterozygous for ornithine carbamoyltransferase deficiency. (N Engl J Med 1990; 322:1641–5.) ORNITHINE carbamoyltransferase is a mitochondrial-matrix enzyme encoded on the X chromosome and expressed in the liver and small intestine. It catalyzes the synthesis of citrulline from carbamoyl phosphate and ornithine. A deficiency of this enzyme results in a disease whose major clinical manifestations — lethargy, vomiting, coma, and cerebral edema — are related in an as yet unexplained way to hyperammonemia. 1 The phenotypic consequences of mutations at the ornithine carbamoyltransferase locus vary. In males, it is most commonly expressed as hyperammonemic coma leading to death in the neonatal period; those who recover from coma have mental retardation and cerebral palsy. . . .

• Publisher: Massachusetts Medical Society
• Subject: Aciduria / Adult / Allopurinol / Biological and medical sciences / Biosynthesis / Carbamoyl phosphate / Central nervous system / Chromatography, High Pressure Liquid / Chromosomes / Coma / DNA methylation / Enterocytes / Enzymes / Excretion / Female / Females / Genetic Carrier Screening - methods / Hepatocytes / Heterozygote / Heterozygotes / High-performance liquid chromatography / Humans / Intellectual disabilities / loci / Males / Medical sciences / Metabolic diseases / Metabolism / Metabolites / Middle Aged / Mitochondria / Mothers / Mutation / Nitrogen / Ornithine / Ornithine carbamoyltransferase / Ornithine Carbamoyltransferase - genetics / Ornithine Carbamoyltransferase Deficiency Disease / Orotic acid / Orotic Acid - urine / Pediatrics / Uridine - analogs & derivatives / Uridine - urine / Urine